Adrenergic modulation of calcitonin gene-related peptide (CGRP)-containing nerve-mediated vasodilation in the rat mesenteric resistance vessel

Brain Res. 1990 Jan 8;506(2):287-90. doi: 10.1016/0006-8993(90)91263-g.

Abstract

Pharmacological studies showed that periarterial nerve stimulation (PNS) of the perfused rat mesenteric vascular bed contracted with endothelin, a vasoconstrictor peptide, in the presence of prazosin (alpha 1-adrenoceptor antagonist) produced a frequency-dependent neurogenic vasodilation when the adrenergic neurotransmission was blocked by the adrenergic neuron blocker, guanethidine. The PNS-evoked vasodilation was attenuated by tetrodotoxin and capsaicin treatment, and was also inhibited when the adrenergic neurotransmitter (norepinephrine; NE) release was left intact in the absence of guanethidine. However, in the combined presence of an alpha 2-adrenoceptor antagonist (yohimbine) and prazosin, PNS caused a marked neurogenic vasodilation even when the neuronal release of NE was left intact. These results suggest that NE released from adrenergic nerves regulates the release of a vasodilator substance, CGRP, through activation of alpha 2-adrenoceptors on CGRP-containing vasodilator nerves.

MeSH terms

  • Adrenergic Fibers / drug effects
  • Adrenergic Fibers / physiology*
  • Animals
  • Calcitonin Gene-Related Peptide / metabolism*
  • In Vitro Techniques
  • Male
  • Norepinephrine / pharmacology
  • Norepinephrine / physiology*
  • Prazosin / pharmacology
  • Rats
  • Rats, Inbred Strains
  • Receptors, Adrenergic, alpha / drug effects
  • Receptors, Adrenergic, alpha / physiology*
  • Splanchnic Circulation / drug effects*
  • Vasodilation / drug effects*

Substances

  • Receptors, Adrenergic, alpha
  • Calcitonin Gene-Related Peptide
  • Norepinephrine
  • Prazosin